Biana Borchenko, FNP-BC a board-certified family nurse practitioner with over 20 years of clinical experience including a decade specializing in peptide therapies, hormone optimization, and longevity medicine leads many of RWAs advanced peptide protocols
For instance, treatment with dioscin, a natural steroid saponin markedly decreased the expression level of miRNA-140-5p, and subsequently activates Nrf2 and silent information regulator factor 2-related enzyme 2 (Sirt2) in cardiac H9c2 cells, thereby upregulating downstream target genes such as HO-1, NQO1, GST, GCLM, and forkhead box O3 (FOXO3a) (Zhao L
GHK-Cu copper peptide, NAD+ and Glutathione for longevity research
Tirzepatide arrived first, delivering unprecedented results in the SURMOUNT clinical trials and earning FDA approval as Zepbound